Intellia Insider Buying Signals Strong Confidence Ahead of Lonvo‑Z Launch
Intellia’s insider buying signals confidence amid strong Q4 results and promising CRISPR therapies Lonvo‑Z and MAGNITUDE‑2, hinting at future growth.
5 minutes to read
Intellia Therapeutics Inc